SCHEMBL3271856

SCHEMBL3271856

Cc1cc(C)c2c(=O)c3cccc(Br)c3oc2c1C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 1/20 0.40
▸ MAOA P21397 11/20 0.40
▸ GLA P06280 1/20 0.39
▸ STING1 Q86WV6 1/20 0.39
▸ ACHE P22303 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ATP1A1 P05023 1/20 0.35
▸ ATP1B1 P05026 1/20 0.35
▸ ATP1A3 P13637 1/20 0.35
▸ ATP1B2 P14415 1/20 0.35
▸ ATP1A2 P50993 1/20 0.35
▸ ATP1B3 P54709 1/20 0.35
▸ FXYD2 P54710 1/20 0.35
▸ ATP1A4 Q13733 1/20 0.35
▸ ESR1 P03372 1/20 0.34
▸ ESR2 Q92731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9378856 0.83 LOXL2 (0.40) LOXL2MAOAGLASTING1ACHE
SCHEMBL3268239 0.80 GLA (0.58) LOXL2MAOAGLASTING1MEN1
Acetic Acid SCHEMBL3273667 0.78 GLA (0.44) MAOAGLASTING1ACHEMAOB
SCHEMBL15678569 0.77 LOXL2 (0.50) LOXL2MAOAGLASTING1EGFR
SCHEMBL3271029 0.76 STING1 (0.71) MAOAGLASTING1MEN1KMT2A
SCHEMBL13395985 0.76 GLA (0.57) MAOAGLASTING1ACHEMAOB
SCHEMBL3267207 0.72 GLA (0.53) MAOAGLASTING1MEN1KMT2A
SCHEMBL16177041 0.70 MAOB (0.45) LOXL2MAOAMAOBESR2
SCHEMBL12093432 0.69 LOXL2 (0.47) LOXL2MAOAMAOBMEN1KMT2A
SCHEMBL29450783 0.69 LOXL2 (0.47) LOXL2MAOAMAOBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8350065-B2 5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same GRAND PHARMA (CHINA) CO., LTD. (CN) 2013-01-08 — — US disclosed
US-8350065-B2 5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same GRAND PHARMA (CHINA) CO., LTD. (CN) 2013-01-08 — — US disclosed
US-8350065-B2 5,6-dimethyl xanthone-4-acetic acid derivatives and method of preparing the same GRAND PHARMA (CHINA) CO., LTD. (CN) 2013-01-08 — — US disclosed
EP-2196463-A1 PREPARATION OF 5,6-DIMETHYLXANTHONE-4-ACETIC ACID, THE DERIVATIVES PREPARED AND PHARMACEUTICAL FORMULATIONS THEREOF Wuhan Grand Pharmaceutical Group Co., Ltd (CN) 2010-06-16 — — EP disclosed
EP-2196463-A1 PREPARATION OF 5,6-DIMETHYLXANTHONE-4-ACETIC ACID, THE DERIVATIVES PREPARED AND PHARMACEUTICAL FORMULATIONS THEREOF Wuhan Grand Pharmaceutical Group Co., Ltd (CN) 2010-06-16 — — EP disclosed
US-20100099754-A1 5,6-DIMETHYL XANTHONE-4-ACETIC ACID DERIVATIVES AND METHOD OF PREPARING THE SAME GRAND PHARMA (CHINA) CO., LTD. (CN) 2010-04-22 — — US disclosed
US-20100099754-A1 5,6-DIMETHYL XANTHONE-4-ACETIC ACID DERIVATIVES AND METHOD OF PREPARING THE SAME GRAND PHARMA (CHINA) CO., LTD. (CN) 2010-04-22 — — US disclosed
US-20100099754-A1 5,6-DIMETHYL XANTHONE-4-ACETIC ACID DERIVATIVES AND METHOD OF PREPARING THE SAME GRAND PHARMA (CHINA) CO., LTD. (CN) 2010-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099754-A1 5,6-DIMETHYL XANTHONE-4-ACETIC ACID DERIVATIVES AND METHOD OF PREPARING THE SAME HCAR2, HAO2, HK2 LOXL2 1152/4885MAOA 131/4885GLA 2459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback